A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma
To access this article, please choose from the options below
PII: S0305-7372(00)90188-9
doi:10.1053/ctrv.2000.0188
PII: S0305-7372(00)90188-9
doi:10.1053/ctrv.2000.0188